Activation of EGFR/ERBB2 via Pathways Involving ERK1/2, P38 MAPK, AKT and FOXO Enhances Recovery of Diabetic Hearts from Ischemia-Reperfusion Injury

Por Akhtar, Saghir, Yousif, Mariam H. M., Chandrasekhar, Bindu, Benter, Ibrahim F.
Publicado em 2012

Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway

Por Akhtar, Saghir, Yousif, Mariam HM, Dhaunsi, Gursev S, Chandrasekhar, Bindu, Al-Farsi, Omama, Benter, Ibrahim F
Publicado em 2012

Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor

Por Akhtar, Saghir, Chandrasekhar, Bindu, Attur, Sreeja, Dhaunsi, Gursev S., Yousif, Mariam H. M., Benter, Ibrahim F.
Publicado no PLoS One (2015)

Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction

Por Akhtar, Saghir, Yousif, Mariam H. M., Dhaunsi, Gursev S., Sarkhouh, Fatma, Chandrasekhar, Bindu, Attur, Sreeja, Benter, Ibrahim F.
Publicado em 2013

Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo

Por Akhtar, Saghir, Al-Zaid, Bashayer, El-Hashim, Ahmed Z., Chandrasekhar, Bindu, Attur, Sreeja, Yousif, Mariam H. M., Benter, Ibrahim F.
Publicado no PLoS One (2015)